Vac-CRT/E7 (Johns Hopkins University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVac-CRT/E7 (Johns Hopkins University)

Drug Alias NameDNA vaccine encoding calreticulin linked to HPV16 E7 (Johns Hopkins University)

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionProtein E7 stimulantsCalreticulin stimulants

TargetsProtein E7Calreticulin

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohns Hopkins Technology Ventures Johns Hopkins University

Active IndicationsN/A

Inactive IndicationsUterine Cervical Neoplasms

Other Information

ATC CodeN/A